What Are the Effects of Stopping Psychiatric Medications?

Summary: A new study from researchers at UCLA calls for mental health professional to be more helpful to patients wishing to stop psychiatric medications.

Source: UCLA.

UCLA professor co-authored new report showing that more than half of people succeed in discontinuing usage of drugs.

Despite numerous obstacles and severe withdrawal effects, long-term users of psychiatric drugs can stop taking them if they choose, and mental health care professionals could be more helpful to such individuals, according to a new study.

While 1 in 6 Americans take a psychiatric medication for serious mental illness, there is little research on people’s experiences coming off the drugs. In the first large-scale study in the United States on this subject, Live and Learn, Inc., in partnership with researchers at the UCLA Luskin School of Public Affairs, UC San Francisco and New York University, began to fill this knowledge gap. Study findings are now available online in Psychiatric Services, a journal published by the American Psychiatric Association.

Surveying 250 long-term users of psychiatric medications who had a diagnosis of serious mental illness and chose to discontinue use, the study found that more than half succeeded in discontinuing usage, despite having little professional support while experiencing severe withdrawal symptoms including insomnia, crying and diarrhea. The majority of survey respondents cited the main reason they attempted to quit centered on health risks of long-term use and side effects.

Of the study’s respondents, 54 percent managed to stay off psychiatric medication for at least one year, with few reporting relapse or re-hospitalization. Eighty-two percent of those who discontinued use reported being “satisfied” with their choice.

“People stop taking their psychiatric medications whether or not they find the drugs helpful, and they do so at all stages of the medication experience — days, weeks, months, or years after taking them,” said David Cohen, professor and Marjorie Crump Chair in Social Welfare at UCLA Luskin and a co-author of the study. “This study is novel because it asks questions about stopping to take medications from the consumer’s point of view.”

Many industry-funded studies have asked patients why they stop taking their medications, but typically with a view to increase compliance, according to Cohen. By contrast, this study asks consumers what they experienced while coming off drugs, who helped them make and carry out their decision, and whether they were satisfied with their attempted or completed discontinuation.

Image shows pills.
The majority of respondents cited the main reasons they attempted to quit psychiatric drugs were health risks of long-term use and side effects. NeuroscienceNews.com image is adaptd from the UCLA news release.

“Over 70 percent of our study sample had taken medication for more than a decade; however, these individuals reported having little to rely on when discontinuing except the internet and social support in order to endure withdrawal. Limiting access to care through cuts to health and psychosocial services can only make that situation worse,” says principal investigator Laysha Ostrow, founder and CEO of Live and Learn, a California-based social enterprise that provides research, technical assistance and knowledge translation services to behavioral health systems. “Most were working with a provider at the time but did not find them helpful in the process. However, even though it was often complicated and difficult, the majority who were able to come off medication completely were satisfied with their decision to do so.”

Cohen said that there are still plenty of challenges for researchers who are examining this topic.

“There’s a lot of work to do to understand how people come off medications and how to help them do so safely, especially when they’re taking several psychiatric medications simultaneously,” he said. “This study didn’t use a probability sample. Though it very carefully selected the 250 respondents, most with over 10 years’ history of taking medications, it should be a priority to confirm or modify these findings with a probability sample.”

About this neuroscience research article

Funding: The study was funded through a grant by the Foundation for Excellence in Mental Health Care.

Source: George Foulsham – UCLA
Image Source: NeuroscienceNews.com image is adapted from the UCLA news release.
Original Research: Abstract for “Discontinuing Psychiatric Medications: A Survey of Long-Term Users” by Laysha Ostrow, Ph.D., M.P.P., Lauren Jessell, L.M.S.W., Manton Hurd, M.S.N., P.M.H.N.P., Sabrina M. Darrow, Ph.D., and David Cohen, Ph.D., M.S.W. in Psychiatric Services. Published online July 17 2017 doi:10.1176/appi.ps.201700070

Cite This NeuroscienceNews.com Article

[cbtabs][cbtab title=”MLA”]UCLA “What Are the Effects of Stopping Psychiatric Medications?.” NeuroscienceNews. NeuroscienceNews, 20 July 2017.
<https://neurosciencenews.com/stopping-psychiatric-medications-7137/>.[/cbtab][cbtab title=”APA”]UCLA (2017, July 20). What Are the Effects of Stopping Psychiatric Medications?. NeuroscienceNew. Retrieved July 20, 2017 from https://neurosciencenews.com/stopping-psychiatric-medications-7137/[/cbtab][cbtab title=”Chicago”]UCLA “What Are the Effects of Stopping Psychiatric Medications?.” https://neurosciencenews.com/stopping-psychiatric-medications-7137/ (accessed July 20, 2017).[/cbtab][/cbtabs]


Discontinuing Psychiatric Medications: A Survey of Long-Term Users

Individuals undergoing long-term psychiatric treatment frequently choose to stop taking psychiatric medications. To enhance service user choice and prevent undesirable outcomes, this first U.S. survey of a large sample of longer-term users sought to increase knowledge about users’ experience of medication discontinuation.

A sample of 250 U.S. adults with a diagnosis of serious mental illness and a recent goal to stop up to two prescribed psychiatric medications, which they had taken for at least nine months, completed a web-based survey about experiences, strategies, and supports during discontinuation.

About half (54%) met their goal of completely discontinuing one or more medications; 46% reported another outcome (use was reduced, use increased, or use stayed the same). Concerns about medications’ effects (for example, long-term effects and side effects) prompted the decision to discontinue for 74% of respondents. They used various strategies to cope with withdrawal symptoms, which 54% rated as severe. Self-education and contact with friends and with others who had discontinued or reduced medications were most frequently cited as helpful. Although more than half rated the initial medication decision with prescribers as largely collaborative, only 45% rated prescribers as helpful during discontinuation. Of respondents who completely discontinued, 82% were satisfied with their decision.

Discontinuing psychiatric medication appears to be a complicated and difficult process, although most respondents reported satisfaction with their decision. Future research should guide health care systems and providers to better support patient choice and self-determination regarding the use and discontinuation of psychiatric medication.

“Discontinuing Psychiatric Medications: A Survey of Long-Term Users” by Laysha Ostrow, Ph.D., M.P.P., Lauren Jessell, L.M.S.W., Manton Hurd, M.S.N., P.M.H.N.P., Sabrina M. Darrow, Ph.D., and David Cohen, Ph.D., M.S.W. in Psychiatric Services. Published online July 17 2017 doi:10.1176/appi.ps.201700070

Feel free to share this Neuroscience News.
Join our Newsletter
I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
Sign up to receive our recent neuroscience headlines and summaries sent to your email once a day, totally free.
We hate spam and only use your email to contact you about newsletters. You can cancel your subscription any time.